Chronic Kidney Disease Global Market Report 2023

Chronic Kidney Disease Global Market Report 2023 – By Diagnosis (Blood Test, Urine Test, Imaging Test, Kidney Biopsy), By Treatment (Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments), By Route of Administration (Oral, Intravenous, Subcutaneous), By End-User (Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : August 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Chronic Kidney Disease Global Market Report 2023

Proud Members Of

Chronic kidney disease is characterized by the inability of damaged kidneys to efficiently filter blood, resulting in excess fluid and blood waste in the body, potentially leading to health problems. It is commonly caused by diabetes, high blood pressure, and obesity. It requires careful, ongoing management and has the potential to proceed to end-stage renal failure requiring dialysis or transplant.

The main diagnostic tests for chronic kidney disease are blood tests, urine tests, imaging tests, and a kidney biopsy. A blood test refers to the scientific examination of a blood sample that will be examined medically. The various types of treatments include drugs, dialysis, kidney transplants, ACE inhibitors, blood tests, and others. These drugs are administered through oral, intravenous, and subcutaneous routes of administration, and are used by various end-users, such as hospitals and clinics, ambulatory surgery centers (ASCS), dialysis centers, and others.

The global chronic kidney disease market is segmented -

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

The global chronic kidney disease market size is expected to grow from $61.51 billion in 2022 to $65.74 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of chronic kidney disease market is expected to reach $82.96billion in 2027 at a CAGR of 6%.

The increasing prevalence of kidney disease is expected to propel the growth of the chronic kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Medication for kidney disease is used to control blood pressure in patients and decrease protein loss to halt the progression of kidney impairment, manage symptoms, and avoid consequences. For instance, in July 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 15%, or 37 million people in the US, were affected by kidney disease. Furthermore, according to a report from the Australian Institute of Health and Welfare, an Australia-based Government agency, the prevalence of kidney replacement therapy in 2020 was 95.4 (per 100,000 population), up from 94 (per 100,000 population) in 2019. Therefore, the increasing prevalence of kidney disease is driving the growth of the chronic kidney disease market.

Major players in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, and ProKidney Corp.

Product innovations are a key trend gaining popularity in the chronic kidney disease market. Companies operating in the chronic kidney disease market are developing innovative products to sustain their position in the market. For instance, in August 2022, Bayer, a Germany-based biotechnology and pharmaceutical company, launched the innovative medicine Kerendia (finerenone) to slow down the progression of chronic kidney disease in diabetes patients. It is a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist and differs from existing treatments. It blocks mineralocorticoid receptor (MR) overactivation, contributing to CKD progression and cardiovascular damage.

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. The acquisition will add CinCor's candidate medicine, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure control in treatment-resistant hypertension, to AstraZeneca's cardiorenal pipeline. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company that develops products to treat resistant and uncontrolled hypertension and chronic kidney disease.

North America was the largest region in the chronic kidney disease market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic kidney disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic kidney disease market consists of revenues earned by entities by providing peritoneal dialysis, in-center hemodialysis, and home hemodialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic kidney disease market also includes sales such as captopril, enalapril, finerenone, and fosinopril used during the treatment procedure. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chronic kidney disease market research report is one of a series of new reports from The Business Research Company that provides chronic kidney disease market statistics, including the chronic kidney disease industry global market size, regional shares, competitors with a chronic kidney disease market share, detailed chronic kidney disease market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic kidney disease industry. This chronic kidney disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Chronic Kidney Disease Market Characteristics

    3. Chronic Kidney Disease Market Trends And Strategies

    4. Chronic Kidney Disease Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On Online Therapy Services Market

    4.2. Ukraine-Russia War Impact On Online Therapy Services Market

    4.3. COVID-19 Impact On Online Therapy Services Market

    5.1. Global Chronic Kidney Disease Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)

    5.2. Global Chronic Kidney Disease Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)

    5.3. Global Chronic Kidney Disease Market Drivers and Restraints

    5.3.1. Drivers Of The Market

    5.3.2. Restraints Of The Market

    6. Chronic Kidney Disease Market Segmentation

    6.1. Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Blood Test

    Urine Test

    Imaging Test

    Kidney Biopsy

    6.2. Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Drugs

    Dialysis

    Kidney Transplant

    ACE Inhibitors

    Blood Test

    Other Treatments

    6.3. Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oral

    Intravenous

    Subcutaneous

    6.4. Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital And Clinics

    Ambulatory Surgery Centers (ASCs)  

    Dialysis Centers

    Other End-Users

    7. Chronic Kidney Disease Market Regional And Country Analysis

    7.1. Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Chronic Kidney Disease Market  

    8.1. Asia-Pacific Chronic Kidney Disease Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.4. Asia-Pacific Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Chronic Kidney Disease Market  

    9.1. China Chronic Kidney Disease Market Overview  

    9.2. China Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.4. China Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Chronic Kidney Disease Market  

    10.1. India Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.3. India Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Chronic Kidney Disease Market  

    11.1. Japan Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.3. Japan Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Chronic Kidney Disease Market  

    12.1. Australia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.3. Australia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Chronic Kidney Disease Market  

    13.1. Indonesia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.3. Indonesia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Chronic Kidney Disease Market  

    14.1. South Korea Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.3. South Korea Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Chronic Kidney Disease Market  

    15.1. Western Europe Chronic Kidney Disease Market Overview

    15.2. Western Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.4. Western Europe Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Chronic Kidney Disease Market  

    16.1. UK Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.3. UK Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Chronic Kidney Disease Market  

    17.1. Germany Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.3. Germany Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Chronic Kidney Disease Market  

    18.5. France Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.6. France Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.7. France Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Italy Chronic Kidney Disease Market  

    19.9. Italy Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.10. Italy Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.11. Italy Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Spain Chronic Kidney Disease Market  

    20.13. Spain Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.14. Spain Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.15. Spain Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. Eastern Europe Chronic Kidney Disease Market  

    21.1. Eastern Europe Chronic Kidney Disease Market Overview

    21.2. Eastern Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. Eastern Europe Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.4. Eastern Europe Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. Russia Chronic Kidney Disease Market  

    22.1. Russia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.2. Russia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. Russia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. North America Chronic Kidney Disease Market  

    23.1. North America Chronic Kidney Disease Market Overview

    23.2. North America Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. North America Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.4. North America Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. USA Chronic Kidney Disease Market  

    24.1. USA Chronic Kidney Disease Market Overview

    24.2. USA Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.3. USA Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.4. USA Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Canada Chronic Kidney Disease Market  

    25.1. Canada Chronic Kidney Disease Market Overview

    25.2. Canada Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Canada Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.4. Canada Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. South America Chronic Kidney Disease Market  

    26.1. South America Chronic Kidney Disease Market Overview

    26.2. South America Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. South America Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.4. South America Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Brazil Chronic Kidney Disease Market  

    27.1. Brazil Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27.2. Brazil Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27.3. Brazil Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    28. Middle East Chronic Kidney Disease Market  

    28.1. Middle East Chronic Kidney Disease Market Overview

    28.2. Middle East Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    28.3. Middle East Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    28.4. Middle East Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    29. Africa Chronic Kidney Disease Market  

    29.1. Africa Chronic Kidney Disease Market Overview

    29.2. Africa Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    29.3. Africa Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    29.4. Africa Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    30. Chronic Kidney Disease Market Competitive Landscape And Company Profiles

    30.1. Chronic Kidney Disease Market Competitive Landscape

    30.2. Chronic Kidney Disease Market Company Profiles

    30.2.1. Pfizer Inc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson and Johnson Services Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AbbVie Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bayer AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Chronic Kidney Disease Market Other Major And Innovative Companies

    31.1. Novartis International AG

    31.2. Sanofi SA

    31.3. Bristol-Myers Squibb Company

    31.4. Abbott laboratories Inc.

    31.5. GlaxoSmithKline PLC

    31.6. Takeda Pharmaceuticals Ltd.

    31.7. Eli Lilly and Company

    31.8. Boehringer Ingelheim International GmbH

    31.9. Amgen Inc.

    31.10. Novo Nordisk AS

    31.11. Siemens Healthineers AG

    31.12. AstraZeneca Pharmaceuticals LP

    31.13. Teva Pharmaceutical Industries Ltd.

    31.14. Beckman Coulter Inc.

    31.15. Kissei Pharmaceutical Co. Ltd.

    32. Global Chronic Kidney Disease Market Competitive Benchmarking

    33. Global Chronic Kidney Disease Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Chronic Kidney Disease Market

    35. Chronic Kidney Disease Market Future Outlook and Potential Analysis

    35.1 Chronic Kidney Disease Market In 2027 - Countries Offering Most New Opportunities

    35.2 Chronic Kidney Disease Market In 2027 - Segments Offering Most New Opportunities

    35.3 Chronic Kidney Disease Market In 2027 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: China, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: China, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: India, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: India, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: India, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Japan, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Japan, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Japan, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: Australia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Australia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Australia, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Indonesia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Indonesia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Indonesia, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: South Korea, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: South Korea, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: South Korea, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Western Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Western Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Western Europe, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: UK, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: UK, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: UK, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: Germany, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: Germany, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: Germany, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: France, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: France, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: France, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Italy, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Italy, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Italy, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Spain, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Spain, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Spain, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 48: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 49: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 50: Eastern Europe, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 51: Russia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 52: Russia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 53: Russia, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 54: North America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 55: North America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 56: North America, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 57: USA, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 58: USA, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 59: USA, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 60: Canada, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 61: Canada, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 62: Canada, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 63: South America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 64: South America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 65: South America, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 66: Brazil, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 67: Brazil, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 68: Brazil, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 69: Middle East, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 70: Middle East, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 71: Middle East, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 72: Africa, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 73: Africa, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 74: Africa, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 75: Pfizer Inc Financial Performance
  • Table 76: Johnson and Johnson Services Inc. Financial Performance
  • Table 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 78: AbbVie Inc. Financial Performance
  • Table 79: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: China, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: China, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: India, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: India, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: India, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Japan, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Japan, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Japan, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: Australia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Australia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Australia, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Indonesia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Indonesia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Indonesia, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: South Korea, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: South Korea, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: South Korea, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Western Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Western Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Western Europe, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: UK, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: UK, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: UK, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: Germany, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: Germany, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: Germany, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: France, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: France, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: France, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Italy, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Italy, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Italy, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Spain, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Spain, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Spain, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 48: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 49: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 50: Eastern Europe, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 51: Russia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 52: Russia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 53: Russia, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 54: North America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 55: North America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 56: North America, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 57: USA, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 58: USA, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 59: USA, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 60: Canada, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 61: Canada, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 62: Canada, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 63: South America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 64: South America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 65: South America, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 66: Brazil, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 67: Brazil, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 68: Brazil, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 69: Middle East, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 70: Middle East, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 71: Middle East, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 72: Africa, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 73: Africa, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 74: Africa, Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 75: Pfizer Inc Financial Performance
  • Figure 76: Johnson and Johnson Services Inc. Financial Performance
  • Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 78: AbbVie Inc. Financial Performance
  • Figure 79: Bayer AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report